Vicc

Cancer patients from the Southeastern United States who are treated with the drug cetuximab, known commercially as Erbitux, are far more likely to suffer severe allergic reactions than patients in other regions of the country. Read More

When your mother told you to eat your vegetables it appears that maternal wisdom had a scientific basis. Researchers with Vanderbilt-Ingram Cancer Center and the Shanghai Cancer Institute in China have discovered a possible link between a diet rich in certain vegetables and a decreased risk for breast cancer. The study appears in the March issue of the American Journal of Clinical Nutrition. Read More

Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center. Read More

Women who receive silicone gel-filled breast implants do not have a higher risk of breast cancer or other cancers and do not experience lower survival rates after breast cancer diagnosis, according to a new report published in the November issue of Annals of Plastic Surgery. This is the first exhaustive review in almost a decade of the health effects of cosmetic breast implants. Read More

Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision. Read More

David K. "Pat" Wilson, former chairman and life member of the Vanderbilt University Board of Trust whose personal and family influence and generosity are evidenced in nearly all areas of the university, died Sunday at home. He was 87. Read More

When the dust settles on a new renovation project involving Vanderbilt-Ingram Cancer Center‘s Henry-Joyce Cancer Clinic, waiting room space and exam rooms will nearly double to help meet the needs of an ever increasing number of cancer patients in Middle Tennessee and beyond. Read More

Vanderbilt-Ingram Cancer Center has received a three-year accreditation with commendation, the highest level of approval, from the Commission on Cancer of the American College of Surgeons (ACoS). Read More

Like a seed needs soil to grow and flourish, a tumor relies on its environment to grow and spread in the body -- something the Vanderbilt-Ingram Cancer Center will be exploring more closely with the help of a new $6.5 million grant from the National Cancer Institute (NCI). Read More

Jennifer A. Pietenpol, Ph.D., has been selected to lead the Vanderbilt-Ingram Cancer Center as interim director. Read More

Raymond DuBois Jr., M.D., Ph.D., will leave his position as director of the Vanderbilt-Ingram Cancer Center later this year to return to his native Texas as provost and executive vice president of academic affairs at M.D. Anderson Cancer Center in Houston. Read More

Vanderbilt University Medical Center has been selected as one of nine teams nationwide to participate in a landmark program from the Robert Wood Johnson Foundation (RWJF) to design and test bold ideas for how consumers can use information technology to better manage their health and navigate the health care system. Read More

Vanderbilt University Medical Center has received a five-year, $1 million grant from the National Foundation for Cancer Research (NFCR) to apply the powerful science of proteomics to drug discovery. Read More

The Meharry/Vanderbilt-Ingram Cancer Partnership has been awarded $14 million by the National Cancer Institute for research that seeks to reduce cancer mortality among African Americans and other minorities. Read More

The Vanderbilt-Ingram Cancer Center and AstraZeneca have developed a master scientific agreement to streamline and integrate collaborations in basic, translational and clinical cancer research, officials with the company and cancer center announced today. Read More

On Saturday, Oct. 21, Vanderbilt University School of Medicine and the Melanoma Research Foundation (MRF) will host an educational symposium for melanoma patients, family and health care providers. Read More

Earlier this year, with surprisingly little media attention, we celebrated a major milestone in the fight against cancer — for the first time in record-keeping history, the number of American lives lost to cancer declined. Read More

The Vanderbilt Breast Center is offering a new class for breast cancer survivors during or after treatment, using the ancient Chinese practice of Qigong, pronounced "chee gung," to help promote renewal and restoration. Read More

When 24-year-old Charles Dougherty checks into Vanderbilt-Ingram Cancer Center tomorrow, he'll be preparing for a treatment that has never been performed before in an adult patient in Nashville, and will be only the second case in Tennessee history. Read More

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant Read More